Montreux Equity Partners Mergers and Acquisitions Summary

Private Equity Profile

In the last 3 years, Montreux Equity Partners has acquired 1 company. It has also invested in 1 other.

Montreux Equity Partners’ most common sectors for investment are medical products (44%) and life science (32%). The Firm’s most common investment types include venture (72%) and buyout (lbo, mbo, mbi) (12%). In total, Montreux Equity Partners has invested in 4 US states and 4 different countries. Its largest (disclosed) acquisition occurred in 2006 when it acquired OREXIGEN Therapeutics for $30M.

In the last 3 years, Montreux Equity Partners has exited 1 company. The Firm’s most common exit type is trade sale (61%). Montreux Equity Partners’ largest (disclosed) exit occurred in 2007 when it sold Cerexa for $480M.

Join Mergr to view Montreux Equity Partners’ full profile and discover more small private equity firms just like it.

M&A Summary

  • M&A Total Activity48
    • M&A Buy Activity25
    • M&A Sell Activity23
  • Total Sectors Invested 7
  • Total Countries Invested 4
  • M&A Buy/Sell Connections 25
  • M&A Advisors 1

Montreux Equity Partners

Four Embarcadero Center, Suite 3720,
San Francisco, California 94111
United States
(650) 234-1200
www.montreuxequity.com
info@mepvc.com

Montreux Equity Partners is a growth investment firm focused on investing in commercial stage companies with category leading products, technologies, and services. Montreux Equity Partners looks to invest $10 to $20 million in fast growing companies with $5 to $50 million in revenue. Montreux Equity Partners was formed in 1993 and is headquartered in San Francisco, California.


Investment Criteria

Sectors of Interest: Consumer Products, Healthcare Services, Information Services, Information Technology, Internet Software and Services, Life Science, Manufacturing, Medical Products, Software

Target Transaction Types: Buyout (LBO, MBO, MBI), Growth Capital, Secondary Buyout, Venture

Geographic Preferences: West US

Transaction Criteria Min Max
Target Revenue 5 50
Target EBITDA - -
Investment Size 10 20
Enterprise Value - -
values in millions of USD

M&A Summary

Buy vs Sell

Year ≤ '15 '16 '17 '18 '19 '20 T
Buy (0.4/yr) # 23 - 1 1 - - 25
vol $30M $30M
Sell (0.2/yr) # 22 - - 1 - - 23
vol $1.7B $1.7B
  48

Most Recent M&A

Company Date Value Type
SI-Bone, Inc. 2018-10-16 - IPO
Santa Clara, California · www.si-bone.com
Active Care Group Ltd 2018-01-31 - Secondary Buyout
Kent, United Kingdom · www.activecaregroup.co.uk
Crown Laboratories, Inc. 2017-10-30 - Growth Capital
Johnson City, Tennessee · www.crownlaboratories.com
GC Aesthetics Ltd. 2015-09-02 - IPO
Dublin, Ireland · www.gcaesthetics.com
Glaukos Corp. 2015-06-25 - IPO
San Clemente, California · www.glaukos.com
MindBody, Inc. 2015-06-18 - IPO
San Luis Obispo, California · www.mindbodyonline.com
Pure Life Renal, Inc. 2014-04-04 - Venture
Hollywood, Florida · www.plrenal.com
Pivot Medical, Inc. 2014-03-07 - Add-on Acquisition
Sunnyvale, California · www.pivotmedical.com
Tobira Therapeutics, Inc. 2013-08-22 - IPO
South San Francisco, California · www.tobiratherapeutics.com
Glaukos Corp. 2013-02-05 - Venture
San Clemente, California · www.glaukos.com
View All >>

M&A by Sector

Sector Current # Value All-time # Value
Medical Products 2 (29%) - 11 (44%) -
Life Science 2 (29%) - 8 (32%) 30M (100%)
Healthcare Services 2 (29%) - 2 (8%) -
Consumer Products - - 1 (4%) -
Internet Software and Services 1 (14%) - 1 (4%) -
Manufacturing - - 1 (4%) -
Software - - 1 (4%) -
Total 7 - 25 $30M

Acquisitions By Geo

State/Country Current # Value All-time # Value
United States 5 (71%) - 22 (88%) 30M (100%)
  California 3 (43%) - 19 (76%) 30M (100%)
  Tennessee 1 (14%) - 1 (4%) -
  Florida 1 (14%) - 1 (4%) -
  Massachusetts - - 1 (4%) -
United Kingdom 1 (14%) - 1 (4%) -
Brazil 1 (14%) - 1 (4%) -
  Pennsylvania 1 (14%) - 1 (4%) -
Ireland - - 1 (4%) -
Total 7 - 25 $30M

Acquisitions by Deal Type

Type Current # Value All-time # Value
Venture 5 (71%) - 18 (72%) -
Buyout (LBO, MBO, MBI) - - 3 (12%) 30M (100%)
Growth Capital 1 (14%) - 2 (8%) -
Secondary Buyout 1 (14%) - 1 (4%) -
Stake Purchase - - 1 (4%) -
Total 7 - 25 $30M

Exits by Deal Type

Type Total # Value
Trade Sale - Public Company 11 (48%) 1.7B (100%)
IPO 8 (35%) -
Trade Sale 4 (17%) -
Total 23 $1.7B

Top M&A Advisors

Financial Deals
Stifel, Nicolaus & Co., Inc.
1

Deal Values

buy # Total
< $100M 1 $30M
TOTAL $30M
Largest OREXIGEN Therapeutics, Inc.
$30M (2006-11-22)
sell # Total
$100M to $1B 5 $1.6B
< $100M 1 $25M
TOTAL $1.7B
Largest Cerexa, Inc.
$480M (2007-01-01)

M&A Connections

Deals %
Acquired from
PE Firm(s)
100%
1 100%
Exited to
Strategic(s)
100%
14 100%

 Subscribe to unlock this and 155,820
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.0K Private Equity Firms
  • 144K M&A Transactions
  • 152K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.1K M&A Advisors
    (Investment Banks and Law Firms)
  • 45K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.